Tesamorelin, a synthetic peptide , is receiving increasing attention for its potential advantages within the therapeutic field. This innovative analogue of growth hormone-releasing hormone (GHRH) functions by stimulating the secretion of HGH from the brain. While primarily investigated for the care of lipodystrophy – a disorder characterized by a